Page last updated: 2024-09-02

opc 21268 and Kidney Failure, Chronic

opc 21268 has been researched along with Kidney Failure, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanno, Y; Okada, H; Saruta, T; Suzuki, H; Yamamura, Y1
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tuchida, H; Yamada, K; Yoshida, S1
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S1

Other Studies

3 other study(ies) available for opc 21268 and Kidney Failure, Chronic

ArticleYear
Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
    Clinical science (London, England : 1979), 1994, Volume: 86, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Kidney; Kidney Failure, Chronic; Male; Piperidines; Quinolones; Rats; Rats, Wistar; Urine

1994
A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
    Clinical nephrology, 1993, Volume: 40, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Quinolones

1993
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
    Clinical nephrology, 1993, Volume: 40, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones

1993